Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Kogner

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
Clinical Chemistry|January 1, 2003
Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrowCatarina Träger, Per Kogner, Magnus Lindskog, et al.
Pediatrics|July 30, 2024
Bone Mineral Density in Survivors of Childhood Cancer: A Meta-AnalysisLilly Velentza, Panagiotis Filis, Mari Wilhelmsson, et al.
International Journal of Oncology|January 23, 2016
Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastomaSusanne Fransson, Malin Östensson, Anna Djos, et al.
International Journal of Oncology|November 18, 2004
Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAILJohn I Johnsen, Ingvild Pettersen, Frida Ponthan, et al.
Cancer Research|November 25, 2003
Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytesSimona Vertuani, Anna De Geer, Victor Levitsky, et al.
International Journal of Cancer|December 15, 2005
Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stressMagnus Lindskog, Helena Gleissman, Frida Ponthan, et al.
International Journal of Oncology|February 13, 2009
The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2AAnnica Wilzén, Staffan Nilsson, Rose-Marie Sjöberg, et al.
BMC Cancer|July 20, 2016
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesisIgor Snapkov, Carl Otto Öqvist, Yngve Figenschau, et al.
Ejhaem|January 30, 2026
Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP-4 as Diagnostic and Predictive BiomarkersGustav Hedberg, Qi Chen, Tadepally Lakshmikanth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous NeuroblastomaYumeng Mao, Nina Eissler, Katarina Le Blanc, et al.
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Clinical Chemistry|January 1, 2003
Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrowCatarina Träger, Per Kogner, Magnus Lindskog, et al.
Pediatrics|July 30, 2024
Bone Mineral Density in Survivors of Childhood Cancer: A Meta-AnalysisLilly Velentza, Panagiotis Filis, Mari Wilhelmsson, et al.
International Journal of Oncology|January 23, 2016
Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastomaSusanne Fransson, Malin Östensson, Anna Djos, et al.
International Journal of Oncology|November 18, 2004
Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAILJohn I Johnsen, Ingvild Pettersen, Frida Ponthan, et al.
Cancer Research|November 25, 2003
Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytesSimona Vertuani, Anna De Geer, Victor Levitsky, et al.
International Journal of Cancer|December 15, 2005
Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stressMagnus Lindskog, Helena Gleissman, Frida Ponthan, et al.
International Journal of Oncology|February 13, 2009
The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2AAnnica Wilzén, Staffan Nilsson, Rose-Marie Sjöberg, et al.
BMC Cancer|July 20, 2016
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesisIgor Snapkov, Carl Otto Öqvist, Yngve Figenschau, et al.
Ejhaem|January 30, 2026
Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP-4 as Diagnostic and Predictive BiomarkersGustav Hedberg, Qi Chen, Tadepally Lakshmikanth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous NeuroblastomaYumeng Mao, Nina Eissler, Katarina Le Blanc, et al.
Pageof 17